Viking Therapeutics (VKTX) Q3 2025 Earnings

23JulConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.58
-0.46
-0.34
-0.22

Details

Expected EPS
-0.446493
Actual EPS
-0.58
Surprise EPS
-0.13
Surprise Percent
+29.9%

Description

Viking Therapeutics (VKTX) has reported earnings of -0.58 per share for Q3 2025.

0 Comments

Share your thoughts